Table 1.
Patients characteristics.
| Patients (total: 158) | Percentage | |
|---|---|---|
| Age (years) | ||
| Median (range) | 65.3 (26.3-88.4) | |
| ECOG | ||
| 0 | 10 | 8.9 |
| 1 | 148 | 91.1 |
| Male | 108 | 68.4 |
| BMI (kg/m2) | ||
| Average (range) | 21.4 (14.3-36.9) | 22.8 |
| < 18.5 kg/m2 | 36 | |
| Recurrence | ||
| Recurrent | 37 | 23.4 |
| De novo | 121 | 76.6 |
| Previous gastrectomy | 50 | 31.6 |
| Previous palliative radiotherapy to stomach | 6 | 3.8 |
| HER2 positive | 21 | 13.3 |
| Primary tumor location | ||
| Cardia | 53 | 33.5 |
| Fundus | 12 | 7.6 |
| Body | 75 | 47.5 |
| Antrum | 50 | 31.6 |
| Pylorus | 24 | 15.2 |
| Linitis plastic | 13 | 8.2 |
| Site of metastasis | ||
| Liver | 37 | 23.4 |
| Peritoneum | 103 | 65.2 |
| Distant lymph nodes | 94 | 59.4 |
| Lung | 22 | 13.9 |
| Bone | 17 | 10.8 |
| Adrenal | 8 | 50.6 |
| Brain | 1 | 0.6 |
| Number of metastatic sites | ||
| 1 | 69 | 43.0 |
| 2 | 59 | 37.3 |
| 3 | 25 | 15.8 |
| 4 | 6 | 3.8 |
| Need tube feeding | 11 | 7.0 |
| Comorbidities | ||
| Diabetes | 34 | 21.5 |
| Hypertension | 63 | 39.9 |
| Hyperlipidemia | 36 | 22.8 |
| Ischemic heart disease | 17 | 10.8 |
| Cerebrovascular disease | 4 | 2.5 |
| Hepatitis B carrier | 12 | 7.6 |
| No. of comorbidities | ||
| 0 | 69 | 43.7 |
| 1 | 35 | 22.2 |
| 2 | 27 | 17.1 |
| 3 | 20 | 12.7 |
| 4 | 7 | 4.4 |
| NoNo. of chemotherapy | ||
| Mono-chemotherapy | 15 | 9.5 |
| Doublet chemotherapies | 143 | 90.5 |
| Dose reduction at first cycle | 44 | 27.8 |